Lee Wheless1, Joshua Black, Anthony J Alberg. 1. Division of Biostatistics and Epidemiology, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
Abstract
BACKGROUND: Based on empirical evidence, a personal history of nonmelanoma skin cancer (NMSC) has been hypothesized to be a risk factor for other cancers. Others hypothesize that NMSC may be a marker of high cutaneous vitamin D synthesis and therefore inversely associated with risk of other malignancies. To reconcile these divergent views, we carried out a systematic review to determine the association between NMSC and subsequent risk of other cancers. METHODS: Bibliographic databases were searched through March 2009. Studies were included if sufficient information was presented to estimate the risk of developing other cancers following NMSC. Studies were reviewed and data were abstracted independently in duplicate with disagreements resolved by consensus. RESULTS: Of the 21 included studies, 15 reported the association between NMSC and risk of all other cancers combined. NMSC was significantly associated with increased risk of another malignancy among cohort studies based on cancer registries summary random-effects relative risk (SRR), 1.12; 95% confidence interval (CI), 1.07-1.17; n = 12 studies) and those with individual-level data (SRR, 1.49; 95% CI, 1.12-1.98; n = 3). In stratified analyses of registry studies, this association held true for both squamous (SRR, 1.17; 95% CI, 1.12-1.23; n = 7) and basal cell carcinoma (SRR, 1.09; 95% CI, 1.01-1.17; n = 7), and both men (SRR, 1.14; 95% CI, 1.09-1.20; n = 12) and women (SRR, 1.10; 95% CI, 1.04-1.15; n = 12). CONCLUSIONS: Strong, consistent evidence indicates that a personal history of NMSC is associated with increased risk of developing other malignancies. IMPACT: For unknown reasons, NMSC may be a risk factor for other cancers.
BACKGROUND: Based on empirical evidence, a personal history of nonmelanoma skin cancer (NMSC) has been hypothesized to be a risk factor for other cancers. Others hypothesize that NMSC may be a marker of high cutaneous vitamin D synthesis and therefore inversely associated with risk of other malignancies. To reconcile these divergent views, we carried out a systematic review to determine the association between NMSC and subsequent risk of other cancers. METHODS: Bibliographic databases were searched through March 2009. Studies were included if sufficient information was presented to estimate the risk of developing other cancers following NMSC. Studies were reviewed and data were abstracted independently in duplicate with disagreements resolved by consensus. RESULTS: Of the 21 included studies, 15 reported the association between NMSC and risk of all other cancers combined. NMSC was significantly associated with increased risk of another malignancy among cohort studies based on cancer registries summary random-effects relative risk (SRR), 1.12; 95% confidence interval (CI), 1.07-1.17; n = 12 studies) and those with individual-level data (SRR, 1.49; 95% CI, 1.12-1.98; n = 3). In stratified analyses of registry studies, this association held true for both squamous (SRR, 1.17; 95% CI, 1.12-1.23; n = 7) and basal cell carcinoma (SRR, 1.09; 95% CI, 1.01-1.17; n = 7), and both men (SRR, 1.14; 95% CI, 1.09-1.20; n = 12) and women (SRR, 1.10; 95% CI, 1.04-1.15; n = 12). CONCLUSIONS: Strong, consistent evidence indicates that a personal history of NMSC is associated with increased risk of developing other malignancies. IMPACT: For unknown reasons, NMSC may be a risk factor for other cancers.
Authors: D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker Journal: JAMA Date: 2000-04-19 Impact factor: 56.272
Authors: Carol A Rosenberg; Philip Greenland; Janardan Khandekar; Aimee Loar; Joao Ascensao; Ana Maria Lopez Journal: Cancer Date: 2004-01-01 Impact factor: 6.860
Authors: Sang Min Park; Tricia Li; Shaowei Wu; Wen-Qing Li; Abrar A Qureshi; Meir Stampfer; Eunyoung Cho Journal: Cancer Epidemiol Date: 2017-02-24 Impact factor: 2.984
Authors: Mackenzie R Wehner; Wilmarie Cidre Serrano; Adi Nosrati; Patrick Michael Schoen; Mary-Margaret Chren; John Boscardin; Eleni Linos Journal: J Am Acad Dermatol Date: 2017-11-13 Impact factor: 11.527
Authors: James Small; Catherine Flanagan; Kent Armeson; David Perry; Richard Marchell; Bruce Thiers; Anthony J Alberg Journal: J Am Acad Dermatol Date: 2016-11 Impact factor: 11.527
Authors: Zhi-Ming Mai; Michael R Sargen; Rochelle E Curtis; Ruth M Pfeiffer; Margaret A Tucker; Elizabeth K Cahoon Journal: J Am Acad Dermatol Date: 2020-04-01 Impact factor: 11.527
Authors: Anthony J Alberg; Timothy J Jorgensen; Ingo Ruczinski; Lee Wheless; Yin Yao Shugart; Yvette Berthier-Schaad; Bailey Kessing; Judith Hoffman-Bolton; Kathy J Helzlsouer; W H Linda Kao; Lesley Francis; Rhoda M Alani; Michael W Smith; Paul T Strickland Journal: Carcinogenesis Date: 2012-10-01 Impact factor: 4.944
Authors: Alexander H Fischer; Timothy S Wang; Gayane Yenokyan; Sewon Kang; Anna L Chien Journal: J Am Acad Dermatol Date: 2016-05-16 Impact factor: 11.527
Authors: Eric A Engels; Ruth Parsons; Caroline Besson; Lindsay M Morton; Lindsey Enewold; Winnie Ricker; Elizabeth L Yanik; Hannah Arem; April A Austin; Ruth M Pfeiffer Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-04-26 Impact factor: 4.254